Ubiquitin-Specific Proteases (USPs) and Metabolic Disorders
International Journal of Molecular Sciences · 06.02.2023 · 24 (4) · 3219
DOI: 10.3390/ijms24043219 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.02.2023. Verfasst von Hiroshi Kitamura. Beteiligte Einrichtung: Laboratory of Comparative Medicine, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu 069-8501, Japan. Hauptthemen laut MEDLINE: Ubiquitin-Specific Proteases, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 149-mal zitiert (Crossref) und nennt 251 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Ubiquitination and deubiquitination are reversible processes that modify the characteristics of target proteins, including stability, intracellular localization, and enzymatic activity. Ubiquitin-specific proteases (USPs) constitute the largest deubiquitinating enzyme family. To date, accumulating evidence indicates that several USPs positively and negatively affect metabolic diseases. USP22 in pancreatic β-cells, USP2 in adipose tissue macrophages, USP9X, 20, and 33 in myocytes, USP4, 7, 10, and 18 in hepatocytes, and USP2 in hypothalamus improve hyperglycemia, whereas USP19 in adipocytes, USP21 in myocytes, and USP2, 14, and 20 in hepatocytes promote hyperglycemia. In contrast, USP1, 5, 9X, 14, 15, 22, 36, and 48 modulate the progression of diabetic nephropathy, neuropathy, and/or retinopathy. USP4, 10, and 18 in hepatocytes ameliorates non-alcoholic fatty liver disease (NAFLD), while hepatic USP2, 11, 14, 19, and 20 exacerbate it. The roles of USP7 and 22 in hepatic disorders are controversial. USP9X, 14, 17, and 20 in vascular cells are postulated to be determinants of atherosclerosis. Moreover, mutations in the Usp8 and Usp48 loci in pituitary tumors cause Cushing syndrome. This review summarizes the current knowledge about the modulatory roles of USPs in energy metabolic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Comparative Medicine, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu 069-8501, Japan.
ORCID-Profile: Hiroshi Kitamura
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Kitamura, H. (2023). Ubiquitin-Specific Proteases (USPs) and Metabolic Disorders. International Journal of Molecular Sciences, 24(4), 3219. https://doi.org/10.3390/ijms24043219
Vancouver
Kitamura H. Ubiquitin-Specific Proteases (USPs) and Metabolic Disorders. International Journal of Molecular Sciences. 2023;24(4):3219. doi:10.3390/ijms24043219
BibTeX
@article{Kitamura2023,
author = {Kitamura, Hiroshi},
title = {Ubiquitin-Specific Proteases (USPs) and Metabolic Disorders},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {4},
pages = {3219},
doi = {10.3390/ijms24043219}
}
EUVIMED